A Study of hBMMSC Injection in Patients With aPAP

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this multicenter, randomized, double-blind, placebo-controlled phase IIb clinical trial is to evaluate the efficacy and safety of intravenous hBMMSC injection in patients with autoimmune pulmonary alveolar proteinosis (aPAP).
Epistemonikos ID: b748e493136423633362f73816b865b8e4e076e5
First added on: Oct 23, 2026